Trial intelligence / Profile preview

Gardasil in mid-adult men (MAM Study)

NCT01432574Phase 2Completed

Sponsor
Moffitt Cancer Center
Start
Feb 2013
Primary completion
May 2014
Modality
Vaccines & Immunotherapeutics
Countries
2
01

Overview

A Phase 2 trial of qHPV vaccine in human papillomavirus infection, sponsored by Moffitt Cancer Center. Started Feb 2013; status: completed.

02

Drugs

qHPV vaccine
03

Conditions

human papillomavirus infection

Beyond the preview

Go deeper on NCT01432574.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01432574.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call